Stockscreener 앱 받기
76.29
1.15%
0.87
시간 외 거래:
76.50
0.21
+0.28%
전일 마감가:
$75.42
열려 있는:
$76.5
하루 거래량:
4.68M
Relative Volume:
0.70
시가총액:
$31.98B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.64
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+6.16%
1개월 성능:
-3.97%
6개월 성능:
-39.29%
1년 성능:
-51.42%
1일 변동 폭
$75.82
$77.99
1주일 범위
$72.11
$77.99
52주 변동 폭
$71.47
$161.77
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
76.29 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
16.96 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.65 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
563.70 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Zoetis receives EU authorization for Newcastle vaccine in poultry - Feedstuffs
Zoetis Inc. $ZTS Shares Bought by Swedbank AB - MarketBeat
Zoetis receives EU approval for Poulvac Procerta HVT-ND vaccine - grafa.com
Portnoy Law Firm Announces Class Action on Behalf of Zoetis, Inc. Investors - GlobeNewswire
Stephens Inc. AR Lowers Stake in Zoetis Inc. $ZTS - MarketBeat
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
'Risk-reward is really starting to pique my interest': Cobb on Zoetis - BNN Bloomberg
Zoetis (ZTS) Gains EU Approval for New Poulvac Vaccine - GuruFocus
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND - Business Wire
ZTS Maintained by HSBC -- Price Target Lowered to $95 - GuruFocus
Zoetis Inc. Faces Securities Fraud Lawsuit Over Misleading Inves - GuruFocus
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost - GlobeNewswire
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
HSBC Adjusts Price Target on Zoetis to $95 From $140 - marketscreener.com
Zoetis Inc. (ZTS) Stock Analysis: Exploring A Potential 58% Upside - DirectorsTalk Interviews
Zoetis: The 60% Decline Was Justified, But Shares Are Finally Buyable - Seeking Alpha
Zoetis Plunges on Earnings Miss and Lowered Guidance - marketscreener.com
Why is Zoetis stock collapsing today? - Investing.com
ZTS INVESTOR DEADLINE: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - TMX Newsfile
Steigerwald Gordon & Koch Inc. Trims Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Montrusco Bolton Investments Inc. - MarketBeat
Zoetis Inc. $ZTS Stake Raised by Moran Wealth Management LLC - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Keybank National Association OH - MarketBeat
Zoetis (NYSE:ZTS) Stock Bought Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Counterpoint Mutual Funds LLC Acquires Shares of 42,789 Zoetis Inc. $ZTS - MarketBeat
Hsbc Holdings PLC Grows Position in Zoetis Inc. $ZTS - MarketBeat
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Should Zoetis’ (ZTS) Shift Into Russell Midcap Indexes After Weaker Guidance Require Investor Action? - simplywall.st
Zoetis Inc (NYSE:ZTS) Dividend Quality Draws Focus - Kalkine Media
Zoetis Inc (NYSE:ZTS) Offers High-Quality Dividend Growth and Strong Profitability at a Discount - ChartMill
Market Watch Rx: Zoetis Shares Slid - Pharmaceutical Executive
Fjarde AP Fonden Fourth Swedish National Pension Fund Increases Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc (ZTS) Stock Up 3.2% and Still Undervalued -- GF Score: 78/100 - GuruFocus
Zoetis Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming DeadlinesZTS - PR Newswire
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis Inc. $ZTS Shares Sold by USS Investment Management Ltd - MarketBeat
iA Global Asset Management Inc. Increases Position in Zoetis Inc. $ZTS - MarketBeat
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire
PHREESIA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class ActionContact Kessler Topaz Meltzer & Check, LLP - PR Newswire
Fund Update: 323,586 ZOETIS (ZTS) shares added to CONFLUENCE INVESTMENT MANAGEMENT LLC portfolio - Quiver Quantitative
Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest - Yahoo Finance
ZTS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ZOETIS INC. INVESTORS WITH LOSSES HAVE UNTIL JULY 27, 2026 - GlobeNewswire
Zoetis (ZTS) Index Shift: A Harbinger for Its Competitive Moat in Companion-Animal Health? - Yahoo Finance
Barclays Lowers Zoetis (NYSE:ZTS) Price Target to $85.00 - MarketBeat
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
1.81%
자본화:
|
볼륨(24시간):